Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GEN-003 HSV-2 Vaccine
NCT01667341Phase 2Completed
- Sponsor
- Genocea Biosciences
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEN-003 in Genital Herpes Type 2 (HSV-2), sponsored by Genocea Biosciences. Started Jul 2012; status: completed.
02
Drugs
GEN-003
03
Conditions
Genital Herpes Type 2 (HSV-2)
Beyond the preview
Go deeper on NCT01667341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667341.